| Dr Mark Chaitowitz, MD | |
|
3411 Wayne Ave, 1st Floor, Bronx, NY 10467-2509 | |
| (718) 920-4137 | |
| Not Available |
| Full Name | Dr Mark Chaitowitz |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 3411 Wayne Ave, Bronx, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922215680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 253878-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.
Senate action on health care reform before the Thanksgiving break seems less likely "as the upper chamber still doesn't have a final version of the bill," The Hill reports.
Older adults who have hip or knee replacement surgery for severe osteoarthritis may take several weeks to recover but appear to have excellent long-term outcomes, according to a report in the July 14 issue of Archives of Internal Medicine.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
› Verified 2 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.
Senate action on health care reform before the Thanksgiving break seems less likely "as the upper chamber still doesn't have a final version of the bill," The Hill reports.
Older adults who have hip or knee replacement surgery for severe osteoarthritis may take several weeks to recover but appear to have excellent long-term outcomes, according to a report in the July 14 issue of Archives of Internal Medicine.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Chaitowitz, MD 3411 Wayne Ave, 1st Floor, Bronx, NY 10467-2509 Ph: (718) 920-4137 | Dr Mark Chaitowitz, MD 3411 Wayne Ave, 1st Floor, Bronx, NY 10467-2509 Ph: (718) 920-4137 |
News Archive
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue.
Senate action on health care reform before the Thanksgiving break seems less likely "as the upper chamber still doesn't have a final version of the bill," The Hill reports.
Older adults who have hip or knee replacement surgery for severe osteoarthritis may take several weeks to recover but appear to have excellent long-term outcomes, according to a report in the July 14 issue of Archives of Internal Medicine.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
› Verified 2 days ago
Selina Sultana Zaman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |